StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00+0.08 (+4.17%)

Close on Nov 17, 2026Market cap $90.49MP/E –Yield –

Genelux price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Genelux's price to sales ratio was 490.1× on Apr 30, 2024.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 2024490.1×+456.7
2023Oct 31, 202333.4×–

More Genelux figures

See a number that looks wrong?